In an older patient with IBS‑related abdominal pain and constipation managed with polyethylene glycol and psyllium, which is the recommended first‑line SSRI: citalopram or escitalopram?

Neither citalopram nor escitalopram is recommended for IBS-C

The AGA explicitly recommends against using SSRIs in patients with IBS, and this applies to both citalopram and escitalopram 1. The British Society of Gastroenterology offers only a weak recommendation for SSRIs with low-quality evidence 2. More critically, in your older patient with IBS-C already managed with polyethylene glycol and psyllium, SSRIs could worsen constipation and have been associated with increased all-cause mortality in IBS populations 3.

Why SSRIs Are Not Recommended

Lack of Efficacy

• SSRIs showed no significant improvement in global IBS symptoms (RR 0.74; 95% CI 0.52-1.06) or abdominal pain in meta-analysis 1
• The confidence intervals actually suggested potential worsening of symptoms
• Studies of citalopram specifically (20-40 mg daily) showed inconsistent results across multiple trials 1, 4

Safety Concerns in IBS

Recent large-scale data reveals antidepressant use in IBS is associated with 35% increased all-cause mortality risk (HR 1.35; 95% CI 1.26-1.45) 3. This finding is consistent across antidepressant subclasses and demographic groups.

Problematic in IBS-C Specifically

SSRIs increase gastrointestinal motility 1, which theoretically could help constipation, but clinical trials show they don't meaningfully improve bowel patterns 5. The constipation-worsening anticholinergic effects and serotonergic effects on gut motility create unpredictable responses.

What You Should Use Instead

For IBS-C with persistent pain despite fiber:

First choice: Tricyclic antidepressants (TCAs) - specifically secondary amines

• Use desipramine or nortriptyline (NOT amitriptyline) due to lower anticholinergic effects that won't worsen constipation 1
• Start 10 mg at bedtime, titrate to 30-50 mg 2
• Strong recommendation with moderate-quality evidence for global symptoms and abdominal pain 2
• TCAs show greater responses for adequate relief and abdominal pain compared to placebo, with clinically meaningful benefits 1

Second choice: Secretagogues

• Linaclotide (strong recommendation, high-quality evidence) - most efficacious for IBS-C 2
• Lubiprostone (strong recommendation, moderate evidence) - less likely to cause diarrhea than linaclotide 2
• These directly address both constipation and visceral pain through different mechanisms

Critical Pitfalls to Avoid

1. Don't use amitriptyline - its high anticholinergic properties will worsen constipation in IBS-C 1

2. Don't prescribe SSRIs hoping to treat subclinical mood symptoms - the therapeutic effect in IBS is independent of effects on depression/anxiety 5, and they simply don't work well for IBS

3. In elderly patients: If you absolutely must use an SSRI despite guidelines (e.g., for comorbid depression), escitalopram requires dose reduction to 10 mg daily maximum due to 50% increased half-life and AUC 6. However, citalopram has similar pharmacokinetic changes in elderly 6. Neither has demonstrated superiority over the other in IBS.

The Direct Answer to Your Question

If forced to choose between citalopram and escitalopram specifically: Neither should be used, but if prescribing for a separate indication (like major depression), escitalopram 10 mg daily would be the technical choice as it's the active S-enantiomer of citalopram with potentially fewer side effects at equivalent doses 6. However, no head-to-head trials exist in IBS populations, and both performed poorly in IBS trials 1, 5, 4.

The evidence is clear: use a secondary amine TCA (desipramine/nortriptyline) or a secretagogue instead 1, 2.